Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage
Massimo Filippi(Vita-Salute San Raffaele University), Katrin Gross‐Paju, Martina Absinta(Johns Hopkins University), S Bozhinov(Vita-Salute San Raffaele University), Penko Shotekov(University of Basel), Pavel Hradílek(University of Basel), Nicola De Stefano(University of Siena), Christiane Ayotte, Claudia Franta(Vita-Salute San Raffaele University), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Sebastiano Galantucci(Vita-Salute San Raffaele University), Svetlana Hristova(Vita-Salute San Raffaele University), Gıancarlo Comı(Vita-Salute San Raffaele University), Hyman H. Rabinovitch(Vita-Salute San Raffaele University), Albert Lamontagne(Vita-Salute San Raffaele University), François Grand’Maison, Petr Kaňovský(Pirogov Russian National Research Medical University), Melissa Petrolini(University of Basel), Elisabetta Pagani(Vita-Salute San Raffaele University), Luca Dall’Occhio(University of Basel), Johannes Weber(Vita-Salute San Raffaele University), Ivan Milanov(Vita-Salute San Raffaele University), M. Kremenchutzky, Maria A. Rocca(Cognitive Neuroimaging Lab), Richard Leckey(Vita-Salute San Raffaele University), Paolo Misci(Vita-Salute San Raffaele University), Roberto Vuotto(Vita-Salute San Raffaele University), C. Lampi(University of Basel), N. Galay, Надежда Делева(Vita-Salute San Raffaele University), Douglas Jeffery(University of New Mexico), H. McFarland(Pirogov Russian National Research Medical University), Stefania Sala(Vita-Salute San Raffaele University), L. H. N. Lee(University of Basel), Igor Petrov(Vita-Salute San Raffaele University), Kenneth A. Bauer(Hadassah Medical Center), L. Haralanov(University of Basel), Giulia Longoni(University of Basel)
Cited by 114
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k